Fostamatinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment.Fostamatinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Fostamatinib Nitroso Impurity 1 CAS NO:NA chemically represented as (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate. Synchemia is the leading manufacturing and exporter of Fostamatinib Nitroso Impurity 1 . We supply Fostamatinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014387 |
| CAS No | NA |
| Mol.F. | C10H15N3O4S |
| Mol.Wt. | 273.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N014388 |
| CAS No | NA |
| Mol.F. | C10H15N3O3S |
| Mol.Wt. | 257.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N014389 |
| CAS No | NA |
| Mol.F. | C14H18N6O3 |
| Mol.Wt. | 318.3 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014390 |
| CAS No | NA |
| Mol.F. | C16H19N3O6S |
| Mol.Wt. | 381.40 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014391 |
| CAS No | NA |
| Mol.F. | C11H14N4O2 |
| Mol.Wt. | 234.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014392 |
| CAS No | NA |
| Mol.F. | C14H19N3O2 |
| Mol.Wt. | 261.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N014393 |
| CAS No | 1184873-13-9 |
| Mol.F. | C18H21N3O |
| Mol.Wt. | 295.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N014394 |
| CAS No | 1184873-14-0 |
| Mol.F. | C19H23N3O |
| Mol.Wt. | 309.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N014395 |
| CAS No | NA |
| Mol.F. | C19H19N9O6 |
| Mol.Wt. | 469.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014396 |
| CAS No | NA |
| Mol.F. | C13H15N3O6 |
| Mol.Wt. | 309.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014397 |
| CAS No | NA |
| Mol.F. | C14H18N4O6 |
| Mol.Wt. | 338.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014398 |
| CAS No | 88381-44-6 |
| Mol.F. | C4H6N2O3S |
| Mol.Wt. | 162.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014399 |
| CAS No | 6238-69-3 |
| Mol.F. | C6H10N2O3 |
| Mol.Wt. | 158.2 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014400 |
| CAS No | NA |
| Mol.F. | C22H30N2O7S |
| Mol.Wt. | 466.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014401 |
| CAS No | NA |
| Mol.F. | C17H18ClN3O |
| Mol.Wt. | 315.80 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014402 |
| CAS No | NA |
| Mol.F. | C13H18N4O2 |
| Mol.Wt. | 262.3 |
| INV STATUS | CUSTOM SYNTHESIS |